US Bancorp
PPH icon

US Bancorp’s VanEck Pharmaceutical ETF PPH Stock Holding History

US Bancorp’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-414
Closed -$36.4K – 4223
2025
Q2 		$36.4K Sell
414
-392
-49% -$34K ﹤0.01% 2930
2025
Q1 		$73.5K Sell
806
-67
-8% -$6.03K ﹤0.01% 2545
2024
Q4 		$75.3K Sell
873
-983
-53% -$88.9K ﹤0.01% 2528
2024
Q3 		$176K Sell
1,856
-386
-17% -$36.7K ﹤0.01% 2098
2024
Q2 		$205K Buy
2,242
+1,211
+117% +$108K ﹤0.01% 1992
2024
Q1 		$93.5K Buy
+1,031
New +$90.3K ﹤0.01% 2403
2021
Q3 		– Sell
-4
Closed – – 4159
2021
Q2 		$0 Buy
+4
New +$285 ﹤0.01% 4059
2017
Q1 		– Sell
-150
Closed -$8K – 3614
2016
Q4 		$8K Buy
150
+84
+127% +$4.49K ﹤0.01% 3088
2016
Q3 		$4K Hold
66
– – ﹤0.01% 3210
2016
Q2 		$4K Hold
66
– – ﹤0.01% 3236
2016
Q1 		$4K Hold
66
– – ﹤0.01% 3228
2015
Q4 		$4K Buy
+66
New +$4.26K ﹤0.01% 3294

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

US Bancorp's PPH Position: Q3 2025 in Review

US Bancorp sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2025, closing a stake of 414 shares — an estimated $36.4K sold.

US Bancorp first reported a position in PPH in Q4 2015 and held it in 12 quarters. The position peaked at $205K in Q2 2024. 127 funds tracked by Wall St. Rank hold PPH as of Q3 2025.

  • US Bancorp reported no remaining VanEck Pharmaceutical ETF position as of Q3 2025 after selling out during the quarter.
  • US Bancorp sold 414 VanEck Pharmaceutical ETF shares in Q3 2025, an estimated $36.4K.
  • US Bancorp first reported a position in VanEck Pharmaceutical ETF in Q4 2015 and held it in 12 quarters.
  • US Bancorp's VanEck Pharmaceutical ETF position peaked at $205K in Q2 2024.
  • 127 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2025.

Based on US Bancorp's 13F filing for Q3 2025, filed 12 Nov 2025.